Jaroslav Pacovský
Charles University in Prague
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jaroslav Pacovský.
BMC Urology | 2017
Miroslav Fajfr; Miroslav Louda; Pavla Paterová; Lenka Ryskova; Jaroslav Pacovský; Josef Košina; Helena Žemličková; Miloš Broďák
BackgroundAgainst a background of rapid increase of β-lactamase-producing or multi-resistant pathogenic bacteria and the resulting lack of effective antibiotic treatment, some older antibiotics have been tested for new therapeutic uses. One of these is fosfomycin, to which according to studies these resistant bacteria are very sensitive. Our study was designed because there is no data on the fosfomycin susceptibility rate in the Czech Republic.MethodIn this study from January 2013 to June 2014 3295 unique isolates of Gram-negative bacteria which had caused urinary tract infections were examined. The antibiotic susceptibility was measured by disk diffusion test. Both EUCAST and CLSI guidelines criteria (for fosfomycin only) were used for the antibiotic susceptibility evaluation.ResultsThe most frequently tested bacterial isolates were Escherichia coli (51.3%, n = 1703), Klebsiella pneumoniae (19.4%, n = 643) and Proteus spp. (11.8%, n = 392). Among all isolates 29.0% (n = 963) were resistant to fluoroquinolones, 11.3% (n = 374) produced extended spectrum β-lactamase and 4.2% (n = 141) produced AmpC β-lactamase. The overall in vitro susceptibility was significantly higher for fosfomycin compared to the other tested per-oral antibiotics (nitrofurantoin, ampicillin, co-trimoxazole, ciprofloxacin and cefuroxime) against all tested Gram-negative rod isolates (excluding Morganella morgani and Acinetobacter spp. isolates). Fosfomycin also remained highly active against those isolates with extended spectrum β-lactamase (ESBL) production (95.8% in Escherichia coli isolates and 85.3% in Klebsiella pneumoniae isolates), unlike other tested per-oral antibiotics, which showed significant (p < 0.0001) susceptibility decrease.ConclusionWe have confirmed in the Czech Republic the very high susceptibility to fosfomycin trometamol of urinary tract infection pathogens, particularly Gram-negative rods including those producing β-lactamase.
Urologie pro praxi | 2011
Miloš Broďák; Josef Košina; Jaroslav Všetička Ph.D; Lukáš Holub; Petr Hušek; Jaroslav Pacovský
Urologie pro praxi | 2010
Miloš Broďák; Josef Košina; Lukáš Holub; Pavel Navrátil; Miroslava Romžová; Miroslav Louda; Petr Kutílek Ph.D; Richard Fiala; Jaroslav Pacovský
Česká urologie | 2012
Petr Hušek; Jaroslav Pacovský; Filip Gabalec; Josef Košina; Jan Cap; Miloš Broďák
Urologie pro praxi | 2012
Miloš Broďák; Josef Košina; Lukáš Holub; Pavel Navrátil; Miroslav Louda; Jaroslav Pacovský
Česká urologie | 2011
Michal Balík; Zdeněk Zoul; Jiří Petera; Jaroslav Pacovský; Miloš Broďák
Urologie pro praxi | 2010
Petr Hušek; Miloš Broďák; Jaroslav Pacovský
Urologie pro praxi | 2009
Ivo Novák Ph.D; Richard Fiala CSc; Jaroslav Pacovský; Miloslav Louda Ph.D; Peter Kuliaček; Libor Janeček; Antonín Krajina; Jan Raupach
Česká urologie | 2018
Lukáš Holub; Petr Hušek; Josef Košina; Jaroslav Pacovský; Miloš Broďák
Česká urologie | 2017
Jiří Špaček; Miroslav Louda; Miroslav Podhola; Jaroslav Pacovský; Miloš Broďák